Applied DNA Sciences financials at a glance

+ Portfolio

The revenue of Applied DNA Sciences is reported as 0.01337 billion Dollars in the fiscal year 2023. The earnings were -0.83 Dollars per share in 2023, which was 47.13 higher than 2022. And about -0.00114 billion Dollars are reported as free cash flow in the financials of Applied DNA Sciences 2023. No dividends were paid to the shareholders of the Applied DNA Sciences stock NasdaqCM:APDN in the financial year 2023.

$13.37M

Revenue

$-0.83

Earnings Per Share

41.39%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

13.37

Earnings Per Share

-0.83

Gross Margin %

41.39

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2022	2020	2018	2017	2016	2015	2014	2013	2012	2011
Rev.	Revenue	N/A	$13.37M	$18.17M	$1.93M	$3.90M	$4.80M	$4.19M	$9.01M	$2.72M	$2.04M	$1.85M	$0.97M
GM %	Gross Margin %	41.39%	41.39%	27.82%	57.14%	69.08%	88.95%	72.04%	95.73%	100.00%	100.00%	100.00%	100.00%
OM	Operating Margin	-81.94%	-81.94%	-76.89%	0.00%	-,298.37%	-,264.48%	-,291.41%	-85.14%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-0.76	$-0.83	$-1.57	$-3.32	$-16.00	$-19.60	$-20.40	$-23.02	$-38.80	$-33.60	$-24.00	$-72.00
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	13.69M	12.91M	5.66M	0.75M	0.68M	0.6M	0.54M	0.35M	0.33M	0.27M	0.2M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M	$-11.14M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$0.00M	$0.00M	$-12.20M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$-0.56	$-0.56	$-1.06	$-3.11	$-9.74	$-11.56	$-18.03	$-16.06	$-25.87	$-31.00	$-17.18	$-24.53

Applied DNA Sciences financials at a glance

Financials

Discover